Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial

BACKGROUND: Compulsivity is a cross-disorder trait underlying phenotypically distinct psychiatric disorders that emerge in childhood or adolescence. Despite the effectiveness of serotonergic compounds in the treatment of obsessive-compulsive disorder, treatment-resistant symptoms remaining in 40 to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Trials
Egile Nagusiak: Häge, Alexander, Banaschewski, Tobias, Buitelaar, Jan K., Dijkhuizen, Rick M., Franke, Barbara, Lythgoe, David J., Mechler, Konstantin, Williams, Steven C. R., Dittmann, Ralf W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794817/
https://ncbi.nlm.nih.gov/pubmed/26983548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1266-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak